Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (II)-78-1 (IGHVII-78-1) is a gene segment belonging to the immunoglobulin heavy chain variable region gene family on human chromosome 14. According to multiple sources, this gene is classified as a pseudogene, meaning it does not encode a functional protein product and is not expressed as a productive immunoglobulin chain in the immune system[1][6][7]. Immunoglobulin variable (V) genes provide the diversity of the antigen-binding sites of antibodies, but pseudogenes in this family, including IGHVII-78-1, retain sequence similarity to functional V genes without being utilized in the immune response. Thus, IGHVII-78-1 is not considered a functional receptor, enzyme, transporter, or therapeutic target. Key supporting details and clarification: - IGHVII-78-1 is specifically annotated as a **pseudogene** and does not participate in producing functional immunoglobulin chains[1][6]. - The gene is a member of the immunoglobulin heavy variable (IGHV) region family, which is crucial for antibody diversity, but only functional IGHV gene segments contribute to the antigen-binding repertoire[1][4][7]. - No disease roles, drug interactions, or functions are attributed to this non-functional segment; it is not a therapeutic, diagnostic, or pharmacological target[1][6][7]. - The nomenclature “IGHVII-78-1”, “IGHV(II)-78-1”, “4-78.1P”, and similar, all refer to this same or highly related non-functional segment. - The presence of “pseudogene” (often abbreviated as "P") and lack of encoded protein, along with absence from immune repertoire studies, confirms its non-functional, non-target status[1][4][6][7]. This entry is, therefore, primarily a genomic annotation without functional, clinical, or therapeutic significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable (II)-78-1 (IGHVII-78-1).